Clinical trial
Treatment of Bacterial Vaginosis With Oral Tinidazole
NCT00229216 · Mission Pharmacal, Industry · Completed
Key facts
| NCT number | NCT00229216 |
|---|---|
| Title | Treatment of Bacterial Vaginosis With Oral Tinidazole |
| Official title | A Phase III Randomized, Multi-center, Double-blind, Double-dummy, Placebo-controlled Treatment Trial of Bacterial Vaginosis With Tinidazole Oral Tablets. |
| Lead sponsor | Mission Pharmacal, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bacterial Vaginosis |
| Intervention type | Drug |
| Interventions | Tinidazole |
| Enrollment | 200 |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 29, 2005 |
| Last update posted | Mar 22, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: